Chime Financial holder plans 3,765-share sale

A shareholder has filed a Rule 144 notice to sell 3,765 CHYM common shares, originally acquired in a 2018 private placement.

Rhea-AI Filing Summary

Chime Financial, Inc. (CHYM) received a notice that Menlo Entrepreneurs Inflection Fund, L.P. intends to sell up to 3,765 shares of its common stock under Rule 144. The shares are to be sold through Merrill Lynch and have an aggregate market value of approximately $130,080.75 as listed.

The shares were originally acquired from the issuer in a private placement for cash on May 16, 2018. The proposed Rule 144 sale date referenced in the notice is September 10, 2026, with trading on Nasdaq.

Key Figures

Shares to be sold: 3,765 shares Aggregate market value: $130,080.75 Acquisition date of shares: May 16, 2018 +1 more

4 metrics

Shares to be sold 3,765 shares Common stock covered by the Rule 144 notice for Menlo Entrepreneurs Inflection Fund, L.P.

Aggregate market value $130,080.75 Market value listed for the 3,765 common shares to be sold under Rule 144

Acquisition date of shares May 16, 2018 Date the common shares were acquired in a private placement for cash

Proposed sale date September 10, 2026 Date referenced for the Rule 144 sale of Chime Financial, Inc. common stock

Key Terms

Rule 144, private placement, aggregate market value, issuer

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

private placement financial

"Common | 05/16/2018 | Private Placement | Issuer"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

aggregate market value financial

"Common | Merrill Lynch ... | 3765 | 130080.75"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

issuer regulatory

"Private Placement | Issuer | | | 3765"

FAQ

What does the Form 144 filing disclose for Chime Financial, Inc. (CHYM)?

It discloses that Menlo Entrepreneurs Inflection Fund, L.P. plans to sell up to 3,765 shares of Chime Financial, Inc. common stock under Rule 144, through Merrill Lynch, with an indicated aggregate market value of about $130,080.75 and a proposed sale date of September 10, 2026.

How many CHYM shares are planned to be sold under this Rule 144 notice?

The notice covers up to 3,765 shares of Chime Financial, Inc. common stock to be sold for the account of Menlo Entrepreneurs Inflection Fund, L.P., as stated in the Form 144 securities information section.

What is the indicated market value of the CHYM shares in this Form 144?

The Form 144 lists an aggregate market value of approximately $130,080.75 for the 3,765 Chime Financial, Inc. common shares proposed to be sold, based on the information provided in the securities information table.

When were the CHYM shares originally acquired that are covered by this Form 144?

The shares were acquired on May 16, 2018 in a private placement from the issuer, for cash, as stated in the securities to be sold section of the Form 144 filing.

What is the proposed sale date and trading market for these CHYM shares?

The Form 144 references a proposed sale date of September 10, 2026, with the common stock listed for trading on Nasdaq, and identifies Merrill Lynch as the broker handling the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 05:53 PM Accepted by SEC EDGAR 09/10/2026 - 05:52 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001772134
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chime Financial, Inc.
SEC File Number	001-42693
Address of Issuer	101 California Street Suite 500 San Francisco CALIFORNIA 94111
Phone	8442446363
Name of Person for Whose Account the Securities are To Be Sold	Menlo Entrepreneurs Inflection Fund, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California Street 18th Floor San Francisco CA 94104	3765	130080.75	347019852	09/10/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/16/2018	Private Placement	Issuer			3765	05/16/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Deborah Carrillo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)